Journal ArticleBMC Med Res Methodol · October 19, 2024
BACKGROUND: Missing data in confounding variables present a frequent challenge in generating evidence using real-world data, including electronic health records (EHR). Our objective was to apply a recently published toolkit for characterizing missing data ...
Full textLink to itemCite
Journal ArticleFertility and sterility · June 2024
ObjectiveTo estimate the effect of platinum-based chemotherapy on live birth (LB) and infertility after cancer, in order to address a lack of treatment-specific fertility risks for female survivors of adolescent and young adult cancer, which limit ...
Full textCite
Journal ArticleJournal of geriatric oncology · November 2023
IntroductionOlder adults living with Alzheimer's disease and related dementias (ADRD) who are then diagnosed with cancer are an understudied population. While the role of cognitive impairment during and after cancer treatment have been well-studie ...
Full textCite
Journal ArticleClinical genitourinary cancer · August 2023
PurposeIntraductal carcinoma of the prostate (IDC-P) is a relatively unstudied feature present in some prostate cancer (PC) diagnoses with several studies suggesting associations with higher Gleason scores (GS) and earlier time to biochemical recu ...
Full textCite
Journal ArticleBJOG : an international journal of obstetrics and gynaecology · June 2023
ObjectiveTo evaluate risks of preterm birth (PTB) and severe maternal morbidity (SMM) in female survivors of adolescent and young adult cancer and assess maternal comorbidity as a potential mechanism. To determine whether associations differ by us ...
Full textCite
Journal ArticleJCO clinical cancer informatics · June 2022
PurposeOlder hospitalized cancer patients face high risks of hospital mortality. Improved risk stratification could help identify high-risk patients who may benefit from future interventions, although we lack validated tools to predict in-hospital ...
Full textCite
Journal ArticleUrology · May 2022
ObjectiveTo determine the odds of accessing telemedicine either by phone or by video during the COVID-19 pandemic.MethodsWe performed a retrospective study of patients who were seen at a single academic institution for a urologic conditio ...
Full textCite
Journal ArticleJournal of the National Cancer Institute · May 2022
BackgroundThere is limited research on how the opioid epidemic and consequent risk reduction policies have affected pain management among cancer patients. The purpose of this study was to analyze how the Opioid Safety Initiative (OSI) implemented ...
Full textCite
Journal ArticleFertility and sterility · May 2022
ObjectiveTo compare antimüllerian hormone (AMH) patterns by cancer status and treatment exposures across 6 years after incident breast cancer using administrative data.DesignIn a cross-sectional design, AMH levels in patients who develope ...
Full textCite
Journal ArticleJournal of the National Cancer Institute · April 2022
BackgroundDespite higher risks associated with prostate cancer, young African American men are poorly represented in prostate-specific antigen (PSA) trials, which limits proper evidence-based guidance. We evaluated the impact of PSA screening, alo ...
Full textCite
Journal ArticleJournal of the National Cancer Institute · April 2022
BackgroundAfrican American patients with bladder cancer have inferior outcomes compared with non-Hispanic White (White) patients. We hypothesize that access to health care is a primary determinant of this disparity. We compared outcomes by race fo ...
Full textCite
Journal ArticleAmerican journal of clinical oncology · February 2022
ObjectivesWhile opioids represent a cornerstone of cancer pain management, the timing and patterns of opioid use in the cancer population have not been well studied. This study sought to explore longitudinal trends in opioid use among Medicare ben ...
Full textCite
Journal ArticleCancer medicine · February 2022
BackgroundOncology rapidly shifted to telemedicine in response to the COVID-19 pandemic. Telemedicine can increase access to healthcare, but recent research has shown disparities exist with telemedicine use during the pandemic. This study evaluate ...
Full textCite
Journal ArticleJournal of the National Comprehensive Cancer Network : JNCCN · February 2022
BackgroundActive surveillance (AS) is a safe treatment option for men with low-risk, localized prostate cancer. However, the safety of AS for patients with intermediate-risk prostate cancer remains unclear.Patients and methodsWe identifie ...
Full textCite
Journal ArticleHealth equity · January 2022
More Americans are being screened for and more are surviving colorectal cancer due to advanced treatments and better quality of care; however, these benefits are not equitably distributed among diverse or older populations. Differential care delivery outco ...
Full textCite
Journal ArticleCancer · December 2021
BackgroundThe safety of active surveillance (AS) for African American men compared with non-Hispanic White (White) men with intermediate-risk prostate cancer is unclear.MethodsThe authors identified patients with modified National Compreh ...
Full textCite
Journal ArticleCancer medicine · December 2021
PurposeCancer patients frequently utilize the emergency department (ED) for a variety of diagnoses both related to and unrelated to their cancer, yet ED outcomes for cancer patients are not well documented. This study sought to define risks and id ...
Full textCite
Journal ArticleInternational journal of radiation oncology, biology, physics · November 2021
PurposeDelivering linguistically competent care is critical to serving patients who have limited English proficiency (LEP) and represents a key national strategy to help reduce health disparities. Current acceptable standards of communication with ...
Full textCite
Journal ArticleInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)A small fraction of cancer patients receiving definitive radiation experience unplanned hospitalizations related to treatment, which potentially leads to substantial morbidity or mortality. Identifying patients at high risk of ...
Full textCite
Journal ArticleInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)Despite recent guideline recommendations, the utilization of low-dose CT (LDCT) for lung cancer screening has remained low. Little is known about the driving factors behind these low rates or the effect of real-world LDCT utili ...
Full textCite
Journal ArticleInternational journal of radiation oncology, biology, physics · November 2021
Purpose/objective(s)Prior research suggests that radiation oncologist provider experience may influence outcomes for radiation treatment modalities requiring greater technical expertise for given disease sites. We investigated whether institution ...
Full textCite
Journal ArticleCancer medicine · October 2021
BackgroundDespite guideline recommendations, utilization of low-dose computed tomography (LDCT) for lung cancer screening remains low. The driving factors behind these low rates and the real-world effect of LDCT utilization on lung cancer outcomes ...
Full textCite
Journal ArticleEuropean urology open science · August 2021
BackgroundMuscle-invasive bladder cancer (MIBC) remains undertreated despite multiple potentially curative options. Both radical cystectomy (RC) with or without neoadjuvant chemotherapy and trimodal therapy (TMT), including transurethral resection ...
Full textCite
Journal ArticleJCO oncology practice · June 2021
PurposeMinority race and lower socioeconomic status are associated with lower rates of opioid prescription and undertreatment of pain in multiple noncancer healthcare settings. It is not known whether these differences in opioid prescribing exist ...
Full textCite
Journal ArticleJournal of Clinical Oncology · May 20, 2021
6581 Background: Hospital readmission are associated with unfavorable patient outcomes and increased costs to the healthcare system. Devising interventions to reduce risks of readmission requires understanding patients at highest ...
Full textCite
Journal ArticleJournal of Clinical Oncology · May 20, 2021
102 Background: Limited research exists on how risk reduction policies in response to the opioid epidemic have impacted pain management among cancer patients. This study investigated the impact of the Veteran’s Health Administrat ...
Full textCite
Journal ArticleJournal of Clinical Oncology · May 20, 2021
e18618 Background: Cancer patients frequently utilize the Emergency Department (ED) for a variety of diagnoses, both related and unrelated to their cancer. Patients with cancer have unique risks related to their cancer and treatm ...
Full textCite
Journal ArticleJournal of Clinical Oncology · May 20, 2021
1512 Background: Elderly hospitalized cancer patients face high risks of inpatient hospital mortality. Identifying patients at high risk of hospital mortality could help with risk stratification, and potentially help inform futur ...
Full textCite
Journal ArticleJournal of Clinical Oncology · May 20, 2021
5004 Background: African-American (AA) men are substantially more likely to present with lethal prostate cancer (PCa) at younger ages than non-Hispanic White men. Despite this disparity, AA men are poorly represented in the prost ...
Full textCite
Journal ArticleJournal of Clinical Oncology · May 20, 2021
e22019 Background: Pediatric cancer patients represent a vulnerable cohort at risk of adverse outcomes after presenting to the emergency department (ED). Given the severity of cancer-related complications and uniqueness of this p ...
Full textCite
Journal ArticleClinical and translational radiation oncology · May 2021
Background and purposeNeutrophil-lymphocyte ratio (NLR) has been associated with overall survival (OS) in non-small cell lung cancer (NSCLC). We aimed to assess the utility of NLR as a predictor of lung cancer-specific survival (LCS) and identify ...
Full textCite
Journal ArticleJAMA network open · May 2021
ImportanceThe association of prostate-specific antigen velocity (PSAV) with clinical progression in patients with localized prostate cancer managed with active surveillance remains unclear and, to our knowledge, has not been studied in African Ame ...
Full textCite
Journal ArticleCancer · May 2021
BackgroundClinical guidelines recommend that providers risk-stratify patients with cancer before prescribing opioids. Prior research has demonstrated that a simple cancer opioid risk score might help identify to patients with cancer at the time of ...
Full textCite
Journal ArticleJCO clinical cancer informatics · March 2021
PurposePancreatic cancer is an aggressive malignancy with patients often experiencing nonspecific symptoms before diagnosis. This study evaluates a machine learning approach to help identify patients with early-stage pancreatic cancer from clinica ...
Full textCite
Journal ArticleJournal of Clinical Oncology · February 20, 2021
399 Background: Outcomes in bladder cancer are disproportionately worse for black patients compared to white patients. We hypothesize these disparities arise in part due to differences in access to healthcare and therefore may be ...
Full textCite
Journal ArticleProstate cancer and prostatic diseases · December 2020
BackgroundThere is concern that African-American men (AA) with low-risk prostate cancer may present with more aggressive disease and thus may not be candidates for active surveillance (AS). However, it is uncertain if poorer outcomes are due to di ...
Full textCite
Journal ArticleJAMA · November 2020
ImportanceThere is concern that African American men with low-risk prostate cancer may harbor more aggressive disease than non-Hispanic White men. Therefore, it is unclear whether active surveillance is a safe option for African American men.O ...
Full textCite
Journal ArticleJournal of Clinical Oncology · October 10, 2020
187 Background: While opioids represent a cornerstone of cancer pain management, the timing and patterns of persistent and high-risk opioid use in the context of the ongoing opioid epidemic are not well studied. This study sought ...
Full textCite
Journal ArticleProstate cancer and prostatic diseases · September 2020
BackgroundIncreasing evidence indicates an association between statins and reduced prostate cancer-specific mortality (PCSM). However, significant bias may exist in these studies. One particularly challenging bias to assess is the healthy user eff ...
Full textCite
Journal ArticleJournal of the National Cancer Institute · July 2020
BackgroundAlthough opioids play a critical role in the management of cancer pain, the ongoing opioid epidemic has raised concerns regarding their persistent use and abuse. We lack data-driven tools in oncology to understand the risk of adverse opi ...
Full textCite
Journal ArticleJAMA network open · July 2020
ImportanceResearchers often analyze cancer registry data to assess for differences in survival among cancer treatments. However, the retrospective, nonrandomized design of these analyses raises questions about study validity.ObjectiveTo e ...
Full textCite
Journal ArticleProstate cancer and prostatic diseases · June 2020
BackgroundCigarette smoking is a risk factor for mortality in several genitourinary cancers, likely due to accumulation of carcinogens in urine. However, in prostate cancer (PC) the link has been less studied. We evaluated differences in prostate ...
Full textCite
Journal ArticleJournal of the National Comprehensive Cancer Network : JNCCN · May 2020
BackgroundPatients with advanced esophageal cancer often experience pain and dysphagia, yet the optimal palliative management remains unclear. This retrospective study evaluated outcomes and adverse effects of palliative radiotherapy (RT) compared ...
Full textCite
Journal ArticleInternational journal of radiation oncology, biology, physics · March 2020
PurposeOlder patients undergoing radiation therapy (RT) for pelvic malignancies are at increased risk for pelvic fracture, which is associated with significant morbidity and mortality. RT techniques such as brachytherapy or intensity modulated RT ...
Full textCite
Journal ArticleProstate cancer and prostatic diseases · December 2019
BackgroundThere is conflicting evidence regarding the association between androgen deprivation therapy (ADT) for prostate cancer (PC) and the risk of developing stroke and thromboembolic events. Our study evaluated the association between ADT use ...
Full textCite
Journal ArticleAnnals of palliative medicine · September 2019
BackgroundInsufficient knowledge of radiotherapy among hospice and palliative medicine (HPM) physicians is a barrier to providing optimal palliative care. We sought to assess the impact of a palliative radiotherapy curriculum on the knowledge, att ...
Full textCite
Journal ArticleJMIR public health and surveillance · May 2019
BackgroundColorectal cancer (CRC) is the second leading cancer-related cause of death in the United States. However, survivorship has been increasing. Both cancer survivors and underserved populations experience unique health-related challenges an ...
Full textCite
Journal ArticleCancer · April 2019
BackgroundThere is no consensus on the association between the use of androgen deprivation therapy (ADT) and the risk of developing depression. This study investigated the association between ADT use and the development of depression, outpatient p ...
Full textCite
Journal ArticleJCO clinical cancer informatics · March 2019
PurposeTreatment decisions about localized prostate cancer depend on accurate estimation of the patient's life expectancy. Current cancer and noncancer survival models use a limited number of predefined variables, which could restrict their predic ...
Full textCite